Barrington Research Reaffirms “Outperform” Rating for Cinemark (NYSE:CNK)

Cinemark (NYSE:CNK)‘s stock had its “outperform” rating reaffirmed by investment analysts at Barrington Research in a note issued to investors on Thursday,Benzinga reports. They presently have a $32.00 price objective on the stock. Barrington Research’s target price would suggest a potential upside of 20.95% from the stock’s previous close.

A number of other brokerages have also recently issued reports on CNK. Wells Fargo & Company lowered their target price on shares of Cinemark from $33.00 to $32.00 and set an “overweight” rating on the stock in a report on Wednesday, January 14th. UBS Group upgraded Cinemark to a “buy” rating in a research note on Tuesday, January 20th. Benchmark reissued a “buy” rating on shares of Cinemark in a report on Thursday, January 15th. Morgan Stanley reaffirmed an “equal weight” rating and set a $28.00 target price (down previously from $35.00) on shares of Cinemark in a report on Thursday, December 18th. Finally, B. Riley Financial decreased their price target on Cinemark from $35.00 to $29.00 and set a “neutral” rating on the stock in a research report on Thursday, January 22nd. Ten equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $32.83.

Cinemark Stock Up 4.3%

Shares of NYSE CNK opened at $26.46 on Thursday. The company has a debt-to-equity ratio of 5.01, a current ratio of 0.76 and a quick ratio of 0.72. The stock has a market capitalization of $3.11 billion, a PE ratio of 25.44, a P/E/G ratio of 2.51 and a beta of 1.13. Cinemark has a one year low of $21.60 and a one year high of $34.01. The business’s fifty day moving average price is $23.90 and its 200-day moving average price is $25.88.

Cinemark (NYSE:CNK) last announced its quarterly earnings data on Wednesday, February 18th. The company reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.29). The firm had revenue of $776.30 million during the quarter, compared to the consensus estimate of $778.41 million. Cinemark had a net margin of 4.93% and a return on equity of 34.33%. The company’s revenue was down 4.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.33 earnings per share. On average, equities research analysts anticipate that Cinemark will post 1.93 EPS for the current year.

Insider Activity

In related news, EVP Melissa Thomas sold 7,944 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $26.05, for a total value of $206,941.20. Following the transaction, the executive vice president directly owned 159,416 shares in the company, valued at approximately $4,152,786.80. This represents a 4.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.10% of the company’s stock.

Hedge Funds Weigh In On Cinemark

A number of institutional investors have recently made changes to their positions in the stock. Maryland State Retirement & Pension System lifted its holdings in shares of Cinemark by 3.1% during the 4th quarter. Maryland State Retirement & Pension System now owns 15,157 shares of the company’s stock worth $352,000 after acquiring an additional 449 shares during the last quarter. Amalgamated Bank raised its position in Cinemark by 1.7% during the third quarter. Amalgamated Bank now owns 29,626 shares of the company’s stock valued at $830,000 after purchasing an additional 488 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in Cinemark by 20.1% during the third quarter. Smartleaf Asset Management LLC now owns 3,027 shares of the company’s stock worth $83,000 after purchasing an additional 506 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its stake in Cinemark by 2.2% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 23,584 shares of the company’s stock worth $548,000 after purchasing an additional 507 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Cinemark by 118.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company’s stock worth $28,000 after purchasing an additional 507 shares in the last quarter.

Cinemark News Roundup

Here are the key news stories impacting Cinemark this week:

• Positive Sentiment: Cinemark declared a quarterly cash dividend of $0.09/share (annualized yield ~1.4%), with record date March 3 and payable March 17 — a direct return of capital that can support investor sentiment.
• Positive Sentiment: Management outlined a $250 million 2026 capex plan focused on expanding premium formats and driving higher box office — a reinvestment push that signals management is prioritizing long‑term revenue mix and guest experience. Cinemark outlines $250M capex plan for 2026
• Neutral Sentiment: Company released its Q4 earnings call transcript and investor slide deck with commentary on trends and strategy; useful detail but no major guidance shock. Q4 2025 Earnings Call Transcript
• Neutral Sentiment: CEO Sean Gamble commented on the Warner/Netflix distribution debate, saying theaters need clearer assurances — commentary that underscores industry uncertainty but also the exhibitor focus on protecting theatrical windows. Deadline: In Warner Merger Battle, Netflix Needs To Take “More Action”
• Negative Sentiment: Cinemark reported Q4 EPS of $0.16, missing consensus (~$0.45) and down year‑over‑year; revenue of $776.3M was slightly below expectations and fell ~4.7% vs. prior year — results that explain short‑term investor concern. MarketBeat: Earnings Report

About Cinemark

Cinemark Holdings, Inc (NYSE: CNK) is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company’s core business involves the presentation of first-run feature films coupled with an array of in‐theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark’s exhibition portfolio encompasses both corporate‐owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large‐format halls.

The company’s product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.